statistiche ricercatore

CAMPIOTTI, LEONARDO

Distribuzione geografica

Continente	#
NA - Nord America	6.938
EU - Europa	3.628
AS - Asia	2.305
SA - Sud America	344
AF - Africa	46
Continente sconosciuto - Info sul continente non disponibili	5
OC - Oceania	4
Totale	13.270

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.836
IT - Italia	1.880
SG - Singapore	838
CN - Cina	497
UA - Ucraina	403
VN - Vietnam	377
SE - Svezia	297
BR - Brasile	283
DE - Germania	267
HK - Hong Kong	259
FR - Francia	182
IE - Irlanda	142
TR - Turchia	141
GB - Regno Unito	124
RU - Federazione Russa	89
FI - Finlandia	69
IN - India	55
NL - Olanda	54
MX - Messico	52
CA - Canada	40
BD - Bangladesh	39
AR - Argentina	23
PL - Polonia	23
JP - Giappone	22
AT - Austria	19
ES - Italia	19
BE - Belgio	17
ZA - Sudafrica	16
EC - Ecuador	12
IQ - Iraq	12
NG - Nigeria	10
SA - Arabia Saudita	9
MD - Moldavia	8
LT - Lituania	7
PE - Perù	7
PK - Pakistan	7
ID - Indonesia	6
JO - Giordania	6
MA - Marocco	6
CL - Cile	5
CO - Colombia	5
PT - Portogallo	5
UZ - Uzbekistan	5
VE - Venezuela	5
EU - Europa	4
KE - Kenya	4
PH - Filippine	4
AE - Emirati Arabi Uniti	3
AI - Anguilla	3
AU - Australia	3
BO - Bolivia	3
CH - Svizzera	3
CR - Costa Rica	3
DZ - Algeria	3
KZ - Kazakistan	3
MK - Macedonia	3
QA - Qatar	3
AM - Armenia	2
AZ - Azerbaigian	2
BG - Bulgaria	2
CZ - Repubblica Ceca	2
EG - Egitto	2
ET - Etiopia	2
GR - Grecia	2
HU - Ungheria	2
IL - Israele	2
IR - Iran	2
JM - Giamaica	2
LK - Sri Lanka	2
MY - Malesia	2
RO - Romania	2
RS - Serbia	2
TN - Tunisia	2
BA - Bosnia-Erzegovina	1
CY - Cipro	1
DK - Danimarca	1
HN - Honduras	1
LB - Libano	1
LU - Lussemburgo	1
ME - Montenegro	1
MN - Mongolia	1
NO - Norvegia	1
NP - Nepal	1
NR - Nauru	1
PR - Porto Rico	1
PS - Palestinian Territory	1
PY - Paraguay	1
SN - Senegal	1
TH - Thailandia	1
TW - Taiwan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	13.270

Salva come PNG Salva come JPEG

Città	#
Milan	1.063
Fairfield	816
Ashburn	594
San Jose	543
Singapore	467
Chandler	440
Woodbridge	414
Houston	344
Seattle	327
Jacksonville	319
Wilmington	319
Cambridge	260
Hong Kong	256
Ann Arbor	210
Dallas	209
Dearborn	180
Nyköping	178
Beijing	159
Princeton	156
Dublin	141
Como	109
New York	109
Boardman	101
Dong Ket	85
Rome	82
The Dalles	82
Ho Chi Minh City	78
Lauterbourg	75
Chicago	70
Izmir	59
San Diego	59
Los Angeles	54
Council Bluffs	51
Munich	50
Kocaeli	44
Hanoi	41
Mexico City	39
Santa Clara	39
Redmond	37
Orem	36
Frankfurt am Main	33
London	33
Ogden	31
São Paulo	27
Helsinki	26
San Mateo	25
Chennai	22
Tokyo	20
Brussels	16
Manchester	16
Warsaw	16
Brooklyn	15
Guangzhou	15
Kunming	14
Nuremberg	14
Amsterdam	13
Johannesburg	13
Toronto	13
Hefei	12
Montreal	12
Phoenix	12
Redwood City	12
Stockholm	12
Atlanta	11
Buffalo	11
Denver	11
Haiphong	11
Nanjing	11
Norwalk	11
Washington	11
Abuja	10
Boston	10
Genoa	10
Mumbai	10
Turku	10
Belo Horizonte	9
Bologna	9
Falkenstein	9
Rio de Janeiro	9
San Francisco	9
Varese	9
Da Nang	8
Shanghai	8
Vienna	8
Cavaria con Premezzo	7
Hangzhou	7
New Delhi	7
Verona	7
Ankara	6
Berlin	6
Dhaka	6
Guayaquil	6
Nanchang	6
Pune	6
Baghdad	5
Brasília	5
Caxias do Sul	5
Chiswick	5
Cincinnati	5
Des Moines	5
Totale	9.416

Salva come PNG Salva come JPEG

Nome	#
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	397
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)	279
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	267
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	244
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	237
Right ventricular remodelling in mild hypertensive patients: role of left ventricular morpho-functional parameters	222
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis	214
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment	209
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML	209
A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene	206
Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality	204
JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential	203
Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases	202
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia	199
sRAGE and early signs of cardiac target organ damage in mild hypertensives	196
In vitro effects of Apixaban on 5 different cancer cell lines	194
Fatal Splenic Rupture in a Previously Undiagnosed Multiple Myeloma: Morphological, Immunophenotypical and Molecular Cytogenetic Analyses	193
Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06	193
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis	192
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register	191
Assessing residual disease in imatinib-treated CML patients by DNA compared to MRNA assays	190
JAK2 mutation and atypical chronic myeloid leukemia	188
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	188
JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia.	187
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub	184
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients	182
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study).	180
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia	180
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	177
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR)	177
Tirosine kinase inhibitors adverse events	176
Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia	176
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register	167
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	165
Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-centre experience	157
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people	156
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards	152
Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia	151
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study	150
What changed in the Italian internal medicine and geriatric wards during the lockdown	149
Metabolic tumour volume and response to therapy in diffuse large B cell lymphoma	148
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry	147
Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study)	144
Molecular monitoring of residual disease in chronic myeloid leukemia by genomic DNA compared with conventional mRNA analysis.	144
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients	142
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells	137
Clinical features, treatment and outcome of patients with low-grade gastric MALT lymphoma: a single centre experience	136
Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis	135
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study	134
Pain and Frailty in Hospitalized Older Adults	131
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients	131
Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study	128
Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06	127
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry	126
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia	125
IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG)	124
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06	123
Composite follicular lymphoma and “early” (in situ and mantle zone growth pattern) mantle cell neoplasia: A rare entity with peculiar cytogenetic and clinical features	122
Antibiotic use and associated factors in a large sample of hospitalised older people	122
Primary non-Hodgkin's lymphoma of the kidney: A case report	121
Tyrosin-Kinase Inhibitors Discontinuation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis	119
CEOP 1-8 regimen for treatment of intermediate-high grade non-Hodgkin's lymphoma in elderly patients	118
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients	118
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)	116
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry	116
Primary testicular non-Hodgkin lymphomas. A clinicopathologic study of nine cases	112
Subacute demyelinating polyneuropathy associated with B-cell lymphoma and IgM antibodies against myelin-associated glycoprotein responsive to rituximab	110
TWO-STEP RESPONSE-ORIENTED INDUCTION PREDICTS LONG-TERM OUTCOME OF ADULT PATIENTS WITH STANDARD- AND HIGH-RISK ACUTE MYELOID LEUKAEMIA (AML): A NORTHERN ITALY LEUKAEMIA GROUP (NILG) STUDY	109
NEXT GENERATION SEQUENCING (NGS) CONFIRMED THE ADVERSE CLINICAL IMPACT OF RUNX1 MUTATIONS IN A SUBSET OF ACUTE MYELOID LEUKEMIA NORMAL KARYOTYPE PATIENTS NEGATIVE FOR RISK DEFINING GENES MUTATIONS AND HOMOGENOUSLY TREATED WITHIN A CLINICAL TRIAL (NILG AML 02/06)	108
MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG)	106
Evaluation of international prognostic factors project for patients with advanced Hodgkin's disease: A single centre experience	106
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)	106
CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE	103
Association of ARA-C, mitoxantrone and etoposide in elderly affected by acute myeloid leucemia	101
Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically	93
PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE	92
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients	89
Post-Treatment Residual Disease Detection by Droplet Digital PCR in Hairy Cell Leukemia: Comparison with Allele Specific PCR and Immunohistochemistry	88
Association of hairy cell leucemia (HCL) with low-grade non Hodgkin lymphoma (NHL) successfully treated with retuximab. A case report	86
Low efficacy of thalidomide in improving response after induction in myeloma patients candidate to high-dose therapy	79
Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer	77
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	76
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study	76
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	75
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy	74
Correction to: Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta‑analysis (Internal and Emergency Medicine, (2023), 18, 2, (535-547), 10.1007/s11739-023-03208-9)	69
Multicentric castleman disease with splenic presentation: report of two rare cases with focus on histopathological features and review of the literature	69
BCL2 in follicular lymphomas (FL): the overrated guy?	69
Integrated genomic, functional, and prognostic characterization of atypical chronic myeloid leukemia	68
Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis	63
A case of multicentric Castleman's disease mimicking non-Hodgkin lymphoma: when splenectomy is diagnostic and therapeutic	62
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry	20
Impact of vitamin D plasma levels on in vitro natural killer cell cytotoxicity against non-small cell lung carcinoma in the presence of nivolumab	10
Idiopathic splanchnic vein thrombosis unmasking a clonal autoinflammatory disease	9
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry	9
Totale	13.431

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	58.109
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	58.109

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	204	0	0	0	0	0	0	0	0	0	0	0	204
2021/2022	915	134	98	40	55	35	106	33	30	53	171	64	96
2022/2023	1.253	130	86	90	128	101	234	1	189	186	37	36	35
2023/2024	1.724	263	260	244	319	303	159	16	27	62	30	17	24
2024/2025	1.369	25	25	252	40	55	75	63	95	148	122	122	347
2025/2026	3.622	294	250	236	504	337	234	644	199	382	248	208	86
Totale													13.431